Tissue kallikreins are a family of extracellular serine proteases consisting of 15 members (1, 2). The genes of this family aligned in tandem on chromosome 19q13.4 represent the largest contiguous group of proteases within the human genome. Tissue kallikreins have attracted great interest as potential biomarkers for various cancers, including prostate, ovarian, breast, testicular, and lung (2, 3). Human Kallikrein 6 (hKLK6) is a member of tissue kallikrein family observed in breast and brain tissues, colon carcinoma cells, and oligodedrocytes (1 - 3). Known protein substrates of hKLK6 are myelin basic protein, the precursor of the A beta amyloid peptide, and plasminogen. Its physiological functions may include the participation in demyelination processes as well as in the progression of inflammatory disease of the CNS. The level of hKLK6 is reduced in brain extracts of Alzheimer patients and increased in serum of patients with ovarian cancer.
Recombinant Human Kallikrein 6 Protein, CF
R&D Systems | Catalog # 5164-SE
Key Product Details
- R&D Systems NS0-derived Recombinant Human Kallikrein 6 Protein (5164-SE)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
Accession Number
Structure / Form
Applications
Product Specifications
Source
Glu17-Lys244, with a C-terminal 10-His tag
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The specific activity is >1300 pmol/min/µg, as measured under the described conditions.
Formulation, Preparation, and Storage
5164-SE
| Formulation | Supplied as a 0.2 μm filtered solution in Sodium Citrate. |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Kallikrein 6/Neurosin
References
- Emami, N. and E.P. Diamandis (2007) Clin Chim Acta 381:78.
- Borgoño, C.A. and E.P. Diamandis (2004) Nat. Rev. Cancer, 4:876.
- Paliouras, M. et al. (2007) Cancer Lett. 249:61.
Alternate Names
Entrez Gene IDs
Gene Symbol
UniProt
Additional Kallikrein 6/Neurosin Products
Product Documents for Recombinant Human Kallikrein 6 Protein, CF
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Recombinant Human Kallikrein 6 Protein, CF
For research use only
Citations for Recombinant Human Kallikrein 6 Protein, CF
Customer Reviews for Recombinant Human Kallikrein 6 Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human Kallikrein 6 Protein, CF and earn rewards!
Have you used Recombinant Human Kallikrein 6 Protein, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
View specific protocols for Recombinant Human Kallikrein 6 Protein, CF (5164-SE):
- Activation Buffer: 50 mM Tris, 0.05% (w/v) Brij-35, pH 8.0
- Assay Buffer: 50 mM Tris, 1.0 M Sodium Citrate, pH 7.5
- Recombinant Human Kallikrein 6/Neurosin (rhKLK6) (Catalog # 5164-SE)
- Lysyl-Endopeptidase, 20 U/mL stock in PBS
- Substrate: BOC-Gln-Ala-Arg-AMC (Catalog # ES014), 10 mM stock in DMSO
- Black 96-well Plate
- Plate Reader with Fluorescence Read Capability
- Dilute rhKLK6 to 200 µg/mL in Activation Buffer.
- Dilute Lysyl-endopeptidase to 2.5 mU/mL in Activation Buffer.
- Combine and mix equal volumes of diluted rhKLK6 and diluted Lysyl-endopeptidase.
- Incubate at room temperature for 30 minutes.
- After incubation, dilute rhKLK6 to 0.5 µg/mL in Assay Buffer.
- Dilute Substrate to 200 µM in Assay Buffer.
- Load into a black well plate 50 µL of 0.5 µg/mL rhKLK6, and start the reaction by adding 50 µL of 200 µM Substrate. Include a Substrate Blank containing 50 µL of Assay Buffer and 50 µL of 200 µM Substrate.
- Read at excitation and emission wavelengths of 380 nm and 460 nm (top read), respectively, in kinetic mode for 5 minutes.
- Calculate specific activity:
|
Specific Activity (pmol/min/µg) = |
Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU) |
| amount of enzyme (µg) |
*Adjusted for Substrate Blank
**Derived using calibration standard 7-Amino, 4-Methyl Coumarin (AMC).
Per Well:
- rhKLK6: 0.025 µg
- Substrate: 100 µM